Results from the phase III stage of a clinical trial demonstrated that acupuncture-like, transcutaneous electrical nerve stimulation may be equally effective as pilocarpine, the current prescription medication in a pill, to treat radiation-induced dry mouth.
Homologous recombination deficiency tests are used routinely in the clinic to determine which patients get PARP inhibitors.
